BioBytes: Machine Learning Could Improve Clinical Trial Diversity

With a growing focus on clinical trial diversity, companies are looking for ways to recruit from historically marginalized communities. Machine learning may help meet these diversity goals. 

Bio Bytes
• Source: Shutterstock

Welcome to In Vivo’s new AI-focused blog, BioBytes, providing news and insight on the growing role of artificial intelligence in biopharma.

Artificial intelligence is proving its value in drug discovery, but it also has a role in addressing issues of equity...

More from Diversity & Inclusion

More from ESG